Catalyst Wire Dossier Catalyst Wire Dossier

ADBRY

TRALOKINUMAB-LDRM · LEO Pharma Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ADBRY, covering 2021-12-27 to 2025-12-17. Get the full timeline:

Most recent: FDA Approved: ADBRY — Supplemental Application (LEO Pharma Inc.)

See pricing